Elucidating the role of the Branched Chain Aminotransferases (BCATc and BCATm) as novel metabolic checkpoints of anti-lymphoma T cell immunity
阐明支链转氨酶(BCATc 和 BCATm)作为抗淋巴瘤 T 细胞免疫的新型代谢检查点的作用
基本信息
- 批准号:10291201
- 负责人:
- 金额:$ 44.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-16 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAmino AcidsBindingBloodBranched-Chain Amino AcidsCancer PatientCell LineageCell SurvivalCell physiologyCellsCellular Metabolic ProcessClinical TrialsClonal ExpansionCytotoxic T-LymphocytesDataDevelopmentDisadvantagedDiseaseDisease remissionDrug resistanceEnzymesFOXP3 geneFeedbackFoundationsFutureGenerationsGenesGoalsGrowthHealth BenefitImmuneImmune responseImmune systemImmunityImmunosuppressionImmunotherapeutic agentImmunotherapyIndividualInterventionJournalsKnock-outKnowledgeLaboratoriesLeadLeucineLinkLymphocyteLymphomaLymphoma cellMalignant NeoplasmsMediatingMedical StudentsMetabolicMetabolic PathwayMetabolismMitochondriaMusNon-MalignantNutrientOutcome StudyPatientsPeer ReviewPerformancePersonal SatisfactionPromoter RegionsProteinsPublishingRegimenRegulatory T-LymphocyteResearchResistanceRoleStudentsT cell differentiationT cell regulationT cell responseT-Cell ActivationT-Cell LymphomaT-LymphocyteT-Lymphocyte SubsetsTestingTranslatingTumor Escapeamino acid metabolismanti-CTLA-4 therapybranched-chain-amino-acid transaminasecancer cellcancer immunotherapeuticscancer immunotherapycancer typecell mediated immune responsecollaborative environmentcombatexhaustionexperiencegraduate studenthands on researchimprovedmouse modelnovelpatient subsetspre-clinicalpreventresponseside effectskillsstemsymposiumtherapeutic targettransaminationtumortumor growthtumor microenvironmenttumor-immune system interactionsundergraduate studentuptake
项目摘要
PROJECT SUMMARY
New immunotherapies targeting lymphomas delivered promising results during recent clinical trials. However,
these therapies were only effective in a small subset of patients with short periods of remission. The results from
these studies suggested the existence of immunosuppression in the tumor microenvironment. Indeed, the
lymphoma microenvironment is a very dynamic network between lymphoma cells and non-malignant
components that may promote tumor growth and consequently drug resistance. Progress in T cell metabolism
has demonstrated that T cells experience a metabolic disadvantage in the tumor microenvironment, which often
manifests in T cell exhaustion that jeopardizes their potential to destroy cancer cells. This reveals a critical need
to explore new (metabolic) approaches to improve T cell performance. Our research team proposes to target the
metabolism of the branched chain amino acids (BCAAs) as a novel metabolic checkpoint of T cell activation in
the lymphoma microenvironment. Our rationale stems from the findings that the BCAA, leucine, is indispensable
for T cells activation, while BCAA metabolism, initiated by the cytosolic (BCATc) and mitochondrial (BCATm)
branched-chain aminotransferases, is a means to direct leucine toward degradation. The objective in this
application is to determine whether a loss of expression of BCATc and BCATm is beneficial for the durability and
functional integrity of T cells during lymphoma eradication in unique pre-clinical mouse models created in our
laboratory. The long-term goal of this application is to provide new means to improve the T cell-mediated immune
response and to address the challenges with T cell-driven anti-lymphoma immunotherapy. The central
hypothesis is that BCATc, supported by BCATm, serves to provide checkpoint control on T cell function by being
a part of a negative feedback loop regulation of T cell activation. Deletion of the BCAT genes from T cells,
individually or in combination, may provide a metabolic advantage of T cells allowing them to remain activated
and to successfully combat lymphoma growth. To test the central hypothesis, we identified three specific aims:
(1) Investigate how the expression of BCATc and BCATm changes upon T cell subset differentiation and whether
the BCAT proteins are essential for T cell lineage commitment and function, (2) Determine whether a blockage
in the transamination of BCAAs enhances the T cell response to lymphoma tumors, and (3) Investigate whether
a loss of expression of BCATc in mouse T cells can overcome the lymphoma resistance to anti-CTLA4 therapy.
Completion of this project will not only provide the opportunity to improve the current treatment options for
lymphoma patients but will also engage students in pre-clinical cancer studies. The students will highly benefit
from acquiring hands-on research experience in cancer, which can be translated into enhanced research skills,
scientific reasoning, and better understanding of treatment approaches.
项目摘要
针对淋巴瘤的新免疫疗法在最近的临床试验中取得了令人鼓舞的结果。然而,在这方面,
这些疗法仅对一小部分缓解期较短的患者有效。的结果
这些研究表明在肿瘤微环境中存在免疫抑制。持续增
淋巴瘤微环境是淋巴瘤细胞和非恶性淋巴瘤细胞之间非常动态的网络。
可能促进肿瘤生长并因此产生耐药性的成分。T细胞代谢研究进展
已经证明T细胞在肿瘤微环境中经历代谢劣势,这通常
表现在T细胞耗竭,这危及它们破坏癌细胞的潜力。这揭示了一个关键的需求
探索新的(代谢)方法来提高T细胞的性能。我们的研究小组建议针对
支链氨基酸(BCAA)代谢作为T细胞活化的新代谢检查点,
淋巴瘤微环境我们的理论基础来自于这样的发现,即BCAA,亮氨酸,
对于T细胞活化,而BCAA代谢,由胞质(BCATc)和线粒体(BCATm)启动
支链氨基转移酶是一种将亮氨酸导向降解的方法。在这方面的目标
本申请的目的是确定BCATc和BCATm表达的丧失是否有利于持久性,
在我们创建的独特临床前小鼠模型中,淋巴瘤根除期间T细胞的功能完整性
实验室本申请的长期目标是提供新的手段来改善T细胞介导的免疫
反应,并解决T细胞驱动的抗淋巴瘤免疫疗法的挑战。中央
假设是由BCATm支持的BCATc通过被
T细胞活化的负反馈环调节的一部分。从T细胞中删除BCAT基因,
单独地或组合地,可以提供T细胞的代谢优势,允许它们保持活化
并成功地对抗淋巴瘤的生长。为了检验中心假设,我们确定了三个具体目标:
(1)研究BCATc和BCATm的表达在T细胞亚群分化后如何变化,以及是否
BCAT蛋白对于T细胞谱系定型和功能是必不可少的,(2)确定阻断是否
在BCAA的转氨作用中增强T细胞对淋巴瘤肿瘤的反应,以及(3)研究是否
小鼠T细胞中BCATc表达的丧失可以克服淋巴瘤对抗CTLA 4治疗的抗性。
该项目的完成不仅将为改善目前的治疗方案提供机会,
淋巴瘤患者,但也将从事临床前癌症研究的学生。学生将受益匪浅。
从获得癌症的实践研究经验,这可以转化为增强的研究技能,
科学推理,更好地理解治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elitsa Antonova Ananieva-Stoyanova其他文献
Elitsa Antonova Ananieva-Stoyanova的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Discovery of nonnatural amino acids promoting alubmin binding
发现促进白蛋白结合的非天然氨基酸
- 批准号:
20K19926 - 财政年份:2020
- 资助金额:
$ 44.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineering RNA-binding proteins with unnatural amino acids and expanded genetic codes
用非天然氨基酸和扩展遗传密码改造 RNA 结合蛋白
- 批准号:
511377-2017 - 财政年份:2017
- 资助金额:
$ 44.35万 - 项目类别:
University Undergraduate Student Research Awards
Monitoring and Tuning a Gas-Binding Heme Protein with Unnatural Amino Acids
用非天然氨基酸监测和调节气体结合血红素蛋白
- 批准号:
9231766 - 财政年份:2016
- 资助金额:
$ 44.35万 - 项目类别:
Research Initiation Award: Toward Bionanoscience - Binding of Amino Acids with Graphene and N-doped Graphene
研究启动奖:迈向生物纳米科学——氨基酸与石墨烯和氮掺杂石墨烯的结合
- 批准号:
1601071 - 财政年份:2016
- 资助金额:
$ 44.35万 - 项目类别:
Standard Grant
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2015
- 资助金额:
$ 44.35万 - 项目类别:
Postgraduate Scholarships - Doctoral
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2014
- 资助金额:
$ 44.35万 - 项目类别:
Postgraduate Scholarships - Doctoral
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2013
- 资助金额:
$ 44.35万 - 项目类别:
Postgraduate Scholarships - Doctoral
IDENTIFICATION OF CONSERVED AMINO-ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
7164303 - 财政年份:2005
- 资助金额:
$ 44.35万 - 项目类别:
IDENTIFICATION OF CONSERVED AMINO-ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
6973859 - 财政年份:2004
- 资助金额:
$ 44.35万 - 项目类别:
IDENTIFICATION OF CONSERVED AMINO ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
6644340 - 财政年份:2002
- 资助金额:
$ 44.35万 - 项目类别: